✦ LIBER ✦

Paclitaxel ± bevacizumab for metastatic breast cancer

Book ID: 120845277
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 120 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816200-00039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E2100: A Phase III Trial of Paclitaxel V

E2100: A Phase III Trial of Paclitaxel Versus Paclitaxel/Bevacizumab for Metastatic Breast Cancer

✍ Kathy D. Miller 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB

Paclitaxel plus Bevacizumab versus Pacli

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

✍ Mayer, E.L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Paclitaxel plus Bevacizumab versus Pacli

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

✍ Miller, Kathy; Wang, Molin; Gralow, Julie; Dickler, Maura; Cobleigh, Melody; Per 📂 Article 📅 2007 🏛 Massachusetts Medical Society 🌐 English ⚖ 287 KB

Bevacizumab in combination with paclitax

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

✍ Konstantin J. Dedes; Klazien Matter-Walstra; Matthias Schwenkglenks; Bernhard C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 718 KB

Bevacizumab in combination with paclitax

Bevacizumab in combination with paclitaxel for HER-2 negative metastatic breast cancer: An economic evaluation

✍ Chap, L.I. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Paclitaxel and bevacizumab in first-line

Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience

✍ Lorenzo Livi, Pierluigi Bonomo, Icro Meattini, Gabriele Simontacchi, Daniela Gre 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 170 KB